Whole-body magnetic resonance imaging in the assessment of muscular involvement in juvenile dermatomyositis/polymyositis patients

被引:24
作者
Castro, T. C. M. [1 ]
Lederman, H. [2 ]
Terreri, M. T. [1 ]
Caldana, W. I. [2 ]
Zanoteli, E. [3 ]
Hilario, M. O. E. [1 ]
机构
[1] Univ Fed Sao Paulo, Dept Paediat, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Dept Radiol, Sao Paulo, Brazil
[3] Univ Sao Paulo, Sch Med, Dept Neurol, BR-05508 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
INFLAMMATORY MYOPATHIES; INTERNATIONAL CONSENSUS; DISEASE-ACTIVITY; FOLLOW-UP; POLYMYOSITIS; CHILDREN; SCORE; TOOL;
D O I
10.3109/03009742.2013.868509
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Our aim was to demonstrate the benefit of whole-body magnetic resonance imaging (WBMRI) as a diagnostic modality in the detection of muscle activity in juvenile dermatomyositis (JDM)/polymyositis (JPM) patients and to correlate these findings with clinical evaluation, laboratory examinations, nailfold capillaroscopy (NFC), and muscle biopsy. Method: Thirty-four patients aged 5.5 to 18.9 years with a diagnosis of JDM/JPM were prospectively evaluated using clinical examination, muscle enzyme determination, the Childhood Myositis Assessment Scale (CMAS), Disease Activity Score (DAS), Manual Muscle Testing (MMT), NFC, and WBMRI. An open muscle biopsy was performed if muscle disease activity was detected on WBMRI. Results: Disease activity was detected in WBMRI in four (11.7%) patients and confirmed by muscle biopsy. All four patients had elevation of at least one muscle enzyme and NFC showed scleroderma patterns in these patients. Conclusions: WBMRI allows us to evaluate the extent and symmetry of muscle disease and inflammatory activity. NFC is an important additional examination to assess disease activity.
引用
收藏
页码:329 / 333
页数:5
相关论文
共 17 条
[1]   Disease activity score for children with juvenile dermatomyositis: Reliability and validity evidence [J].
Bode, RK ;
Klein-Gitelman, MS ;
Miller, ML ;
Lechman, TS ;
Pachman, LM .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (01) :7-15
[2]   POLYMYOSITIS AND DERMATOMYOSITIS .2. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (08) :403-407
[3]   POLYMYOSITIS AND DERMATOMYOSITIS .1. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) :344-347
[4]   An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM) [J].
Brown, V. E. ;
Pilkington, C. A. ;
Feldman, B. M. ;
Davidson, J. E. .
RHEUMATOLOGY, 2006, 45 (08) :990-993
[5]  
LEE P, 1983, J RHEUMATOL, V10, P930
[6]  
Lovell DJ, 1999, ARTHRITIS RHEUM-US, V42, P2213, DOI 10.1002/1529-0131(199910)42:10<2213::AID-ANR25>3.0.CO
[7]  
2-8
[8]   Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study [J].
Mathiesen, P. ;
Hegaard, H. ;
Herlin, T. ;
Zak, M. ;
Pedersen, F. K. ;
Nielsen, S. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2012, 41 (01) :50-58
[9]   The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) - clinical characteristics of children recruited within the first 5 yr [J].
McCann, L. J. ;
Juggins, A. D. ;
Maillard, S. M. ;
Wedderburn, L. R. ;
Davidson, J. E. ;
Murray, K. J. ;
Pilkington, C. A. .
RHEUMATOLOGY, 2006, 45 (10) :1255-1260
[10]   Whole-body MR imaging in the diagnosis of polymyositis [J].
O'Connell, MJ ;
Powell, T ;
Brennan, D ;
Lynch, T ;
McCarthy, CJ ;
Eustace, SJ .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 179 (04) :967-971